Concurrently, CSPG4P12 overexpression results in a significant reduction in the levels of Bcl-2 [20], an anti-apoptotic protein that typically contributes to cell survival and resistance to cell death mechanisms in cancer cells [35]. The gene discussed is BCL2; the disease is cancer.